RVAC Medicines Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Employees
-
56
- Latest Deal Type
-
Out of Business
RVAC Medicines General Information
Description
Developer of an mRNA platform designed to build a diverse pipeline of innovative medicines. The company provides end-to-end GMP manufacturing capabilities, MSAT infrastructure for process scale-up and tech transfer, and develops single and multi-mRNA/DNA products, enabling healthcare professionals to tackle infectious diseases.
Contact Information
Website
www.rvacmed.comCorporate Office
- 22-05 Millenia Tower
- 1 Temasek Avenue
- Singapore, 039192
- Singapore
Corporate Office
- 22-05 Millenia Tower
- 1 Temasek Avenue
- Singapore, 039192
- Singapore
RVAC Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 14-Mar-2026 | Completed | Out of Business | |||
| 2. Early Stage VC (Series B) | 26-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 06-Apr-2022 | Completed | Pre-Clinical Trials |
RVAC Medicines Comparisons
Industry
Financing
Details
RVAC Medicines Competitors (35)
One of RVAC Medicines’s 35 competitors is Vir Biotechnology, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Mustang Bio | Formerly VC-backed | Waltham, MA | ||||
| Histogen | Formerly VC-backed | San Ramon, CA | ||||
| Novavax | Corporation | Gaithersburg, MD |
RVAC Medicines Patents
RVAC Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025227301-A1 | Untranslated regions and uses thereof | Pending | 28-Apr-2024 | ||
| EP-4750907-A1 | Method of mrna manufacture | Pending | 26-Jul-2023 | ||
| WO-2025024734-A1 | Method of mrna manufacture | Inactive | 26-Jul-2023 | ||
| WO-2025024734-A8 | Method of mrna manufacture | Inactive | 26-Jul-2023 | ||
| EP-4734981-A1 | Ionizable lipids and lipid nanoparticle compositions for delivery of nucleic acids | Pending | 30-Jun-2023 | A61K45/06 |
RVAC Medicines Signals
RVAC Medicines FAQs
-
When was RVAC Medicines founded?
RVAC Medicines was founded in 2021.
-
Where is RVAC Medicines headquartered?
RVAC Medicines is headquartered in Singapore, Singapore.
-
What is the size of RVAC Medicines?
RVAC Medicines has 56 total employees.
-
What industry is RVAC Medicines in?
RVAC Medicines’s primary industry is Drug Discovery.
-
Is RVAC Medicines a private or public company?
RVAC Medicines is a Private company.
-
What is RVAC Medicines’s current revenue?
The current revenue for RVAC Medicines is .
-
Who are RVAC Medicines’s competitors?
Vir Biotechnology, etherna, Mustang Bio, Histogen, and Novavax are some of the 35 competitors of RVAC Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process